Ads
related to: exondys
Search results
Sarepta data show new Duchenne drug’s potency, but highlight side effects
BioPharma Dive via Yahoo Finance· 5 months agoA successor medicine to Sarepta's Exondys 51 appeared better at boosting dystrophin protein...
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoEarlier today, we released our financial results for the third quarter of 2022. Joining us on the...
Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
Zacks via Yahoo Finance· 4 months agoSarepta Therapeutics, Inc. SRPT reported earnings of 47 cents per share in the fourth quarter of...
Sarepta (SRPT) Down on Clinical Hold on DMD Candidate SRP-5051
Zacks via Yahoo Finance· 2 years agoThe FDA places Sarepta's (SRPT) next-generation DMD candidate, SRP-5051, on clinical hold, following...
Why Dyne Therapeutics, With A 166% Run This Year, Just Catapulted Again
Investor's Business Daily· 1 month agoTop-notch biotech stock Dyne Therapeutics broke out Monday after the company unveiled promising test...
Why Is Sarepta Therapeutics (SRPT) Up 13.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoIt has been about a month since the last earnings report for Sarepta Therapeutics (SRPT). Shares...
Dyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Zacks via Yahoo Finance· 1 month agoDyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage...
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
Zacks via Yahoo Finance· 5 months agoShares of Sarepta Therapeutics, Inc. SRPT were up 5.4% on Jan 8 after the company announced robust...
Duchenne Muscular Dystrophy (DMD) Treatment
Verywell Health via Yahoo News· 1 month agoInsights Into Treatment Advancements Medically reviewed by Nicholas R. Metrus, MDMedically reviewed by Nicholas R. Metrus, MD Duchenne muscular dystrophy...
Clinical Hold on Sarepta's (SRPT) DMD Candidate Lifted by FDA
Zacks via Yahoo Finance· 2 years agoThe FDA lifts the clinical hold placed on Sarepta's (SRPT) next-generation DMD candidate, SRP-5051,...
Ad
related to: exondys
